Pro-Dex CFO plans sale of 2,300 company shares

PRO DEX INC’s CFO filed a Rule 144 notice to potentially sell 2,300 common shares valued at about $168,843.

Available on EDGAR 09/08/2026 - 06:00 PM EDT Accepted by SEC EDGAR 09/08/2026 - 06:00 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

PRO DEX INC (PDEX) received a Rule 144 notice from its Chief Financial Officer, Alisha Charlton, covering a proposed sale of 2,300 shares of common stock through Charles Schwab.

The notice reports an aggregate market value of $168,843 for these shares, based on the NASDAQ Capital Market closing price on September 4, 2026, with an approximate sale date of September 9, 2026 and 3,203,334 shares outstanding.

Key Figures

Shares proposed for sale: 2,300 shares Aggregate market value: $168,843 Shares outstanding: 3,203,334 shares +2 more

5 metrics

Shares proposed for sale 2,300 shares Common stock covered by the Rule 144 notice for PRO DEX INC

Aggregate market value $168,843 Value of 2,300 shares based on September 4, 2026 NASDAQ Capital Market closing price

Shares outstanding 3,203,334 shares PRO DEX INC common shares outstanding cited in the Form 144

Approximate date of sale September 9, 2026 Target date for the proposed Rule 144 sale

Vesting date July 1, 2026 Date Performance Awards vest for the 2,300 shares to be sold

Key Terms

Rule 144, Performance Awards, equity compensation, NASDAQ Capital Market

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Performance Awards financial

"vesting of Performance Awards | Issuer | | | 2300"

equity compensation financial

"2300 | 07/01/2026 | equity compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

NASDAQ Capital Market market

"closing sales price of the Issuer's common stock on the NASDAQ Capital Market"

The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did PDEX disclose in this Form 144 filing?

The filing reports that PRO DEX INC’s CFO, Alisha Charlton, filed a Rule 144 notice for a proposed sale of 2,300 shares of the company’s common stock through broker Charles Schwab.

How many PDEX shares are covered by Alisha Charlton’s Rule 144 notice?

The notice covers a proposed sale of 2,300 shares of PRO DEX INC common stock. These shares are tied to the vesting of Performance Awards scheduled for July 1, 2026.

What is the reported value of the PDEX shares in this Form 144?

The Form 144 reports an aggregate market value of $168,843 for the 2,300 shares of PRO DEX INC common stock, using the closing sales price on the NASDAQ Capital Market on September 4, 2026.

When are the PDEX shares expected to be sold under this Rule 144 notice?

The approximate date of sale disclosed for the PRO DEX INC shares is September 9, 2026, as stated in the Rule 144 notice filed by the company’s Chief Financial Officer.

How many PDEX shares were outstanding at the time referenced in the Form 144?

The Form 144 lists 3,203,334 shares of PRO DEX INC common stock outstanding, providing context for the size of the 2,300-share proposed sale.

What is the source of the PDEX shares to be sold by the CFO?

The shares are to be acquired from the issuer upon the vesting of Performance Awards on July 1, 2026, categorized as equity compensation to the Chief Financial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001431777
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Pro Dex Inc
SEC File Number	000-14942
Address of Issuer	2361 McGaw Avenue Irvine CALIFORNIA 92614
Phone	949-769-3200
Name of Person for Whose Account the Securities are To Be Sold	Alisha Charlton
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Chief Financial Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Charles Schwab 211 Main Street San Francisco CA 94105	2300	168843.00	3203334	09/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/01/2026	vesting of Performance Awards	Issuer			2300	07/01/2026	equity compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The aggregate value reported above is based on the closing sales price of the Issuer's common stock on the NASDAQ Capital Market on September 4, 2026.
Date of Notice	09/08/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Alisha Charlton
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)